MARGRET LEVIN: Open Payments
NPI 1043468325 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,347 in 73 payments from 14 companies in 2025. Trend: 2023 $2,153 · 2024 $2,979 · 2025 $2,347
Food & beverage: $2,347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $974 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $266 |
| Lilly USA, LLC | 2 | $245 |
| GENZYME CORPORATION | 3 | $184 |
| Sumitomo Pharma America, Inc. | 10 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Astellas Pharma US Inc | 3 | $92 |
| Amgen Inc. | 4 | $76 |
| Aimmune Therapeutics, Inc. | 2 | $58 |
| Novo Nordisk Inc | 3 | $58 |
Products named: UBRELVY, QULIPTA, JARDIANCE, Linzess, DUPIXENT, GEMTESA, MOUNJARO, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
